Bacterial Vaginosis

Bacterial Vaginosis

For recurrent BV, it can be frustrating. It is common, and many women often feel isolated and hopeless. Recurrence of bacterial vaginosis is typical.

Bacterial vaginosis is the most common cause of vaginitis in women aged 15–44, affecting approximately 21 million women. It is a common bacterial infection that causes inflammation and discomfort in the vagina. BV occurs due to an overgrowth of harmful bacteria that disrupts the natural pH balance of the vagina.

Risk factors include unprotected sex, new sexual partners, douching, and the use of certain antibiotics. Symptoms may include itching, burning, redness, swelling, and a characteristic fishy-smelling gray or green vaginal discharge. However, some women may not experience any symptoms.

There is significant overlap in symptoms among vaginal infections, which can make diagnosis confusing. Yeast infections and sexually transmitted infections (STIs) may present with similar symptoms.

Ideally, you should consult a healthcare provider for a pelvic exam and vaginal culture to ensure an accurate diagnosis.

Several antibiotics are used to treat BV, including metronidazole and clindamycin. These medications can be taken orally or applied vaginally as creams or gels.

Oral metronidazole may cause side effects such as nausea, vomiting, and darkened urine. Alcohol should be avoided during treatment, as it can lead to severe nausea and vomiting.

BV often recurs, and repeated treatment may be necessary. In some cases, extended treatment lasting 3 to 6 months may be required.

Up to 66% of women experience recurrent BV infections within a year after initial treatment.

“Symptoms of bacterial vaginosis can be incredibly uncomfortable and disrupt people’s daily lives. The discomfort becomes compounded by frustration when this condition returns repeatedly and is difficult to treat. Partner therapy offers another avenue for preventing recurrence and helping people feel better faster.”

— Christopher Zahn, MD, FACOG, Chief of Clinical Practice and Health Equity and Quality at ACOG

The American College of Obstetricians and Gynecologists (ACOG) continues to review new research on male partner therapy. Emerging evidence suggests sexual activity may play a role in recurrence. In some cases, treating sexual partners may help reduce recurrence rates.

Recommended partner treatment may include oral Flagyl (500 mg, three times daily) and topical Cleocin applied to the penis twice daily for partners of women with recurrent BV.

Most cases of BV do not cause long-term harm to reproductive or maternal health. However, BV can increase susceptibility to STIs and pelvic inflammatory disease, which may lead to infertility.

During pregnancy, BV has been associated with premature delivery and low birth weight.

Many vaginal infections share similar symptoms, including:

  • Bacterial infections
  • Yeast infections
  • Sexually transmitted infections such as Chlamydia and Trichomoniasis
  • Allergic reactions to latex or hygiene products
  • Low estrogen levels in menopausal women
  • Vaginal tears

STIs are transmitted through direct contact between partners. Risk factors include unprotected sex, multiple partners, a history of STIs, and impaired judgment due to alcohol or drug use.

The only reliable way to distinguish BV from an STI is through medical evaluation and laboratory testing. Since both conditions can impact fertility, prioritizing vaginal health is essential.

0 comments

Leave a comment